Soligenix Says FDA Grants Type A Meeting Regarding New Drug Application For HyBryte
(RTTNews) - Biopharmaceutical company Soligenix, Inc. (SNGX) announced Monday that the U.S. Food and Drug Administration (FDA) has granted a Type A meeting to discuss the contents of a refusal to file (RTF) letter previously issued regarding the Company's new drug application (NDA) for HyBryte (synthetic hypericin) in the treatment of early stage cutaneous T-cell lymphoma (CTCL), a rare cancer.
The company has successfully demonstrated statistically significant results in a Phase 3 clinical trial.
The company said it intends to provide a further update once it receives the minutes from the meeting or when it has more clarity on next steps, which is anticipated by or before the end of April.
For More Such Health News, visit rttnews.com
read more
Euro Rallies Amid Ukraine Peace Plan
The euro firmed against its major counterparts on Monday, amid the prospect of higher defense spending in Europe to deter Russian aggression.
RTTNews
|
7h 16min ago
Canadian Market Down Firmly In Negative Territory
The Canadian market, which retreated after a positive start Monday morning, continues to languish in negative territory well past noon, with stocks from technology and energy sectors reeling under selling pressure.
RTTNews
|
7h 17min ago
Swiss Market Ends On Bright Note
The Switzerland market started off on a sluggish note on Monday amid tariff concerns, but gained in strength as the day progressed as investors picked up stocks from across several sectors.
RTTNews
|
8h 10min ago
European Markets Close On Firm Note As Defense Stocks Rally
European markets closed higher on Monday, led by strong gains posted by defense stocks amid rising prospects of increased military spending by European countries.
Investors also bet on a rate cut by the European Central Bank this week.
RTTNews
|
8h 24min ago
U.S. Construction Spending Unexpectedly Dips 0.2% In January
Construction spending in the U.S. unexpectedly edged modestly lower in the month of January, according to a report released by the Commerce Department on Monday. The Commerce Department said construction spending slipped by 0.2 percent to an annual rate of $2.193 trillion in January after climbing by 0.5 percent to a revised rate of $2.196 trillion in December.
RTTNews
|
11h 34min ago
U.S. Manufacturing Index Edges Lower But Still Indicates Modest Growth In February
A report released by the Institute for Supply Management on Monday showed its reading on U.S. manufacturing edged slightly lower in February, although the index still indicated growth in the sector for the second straight month. The ISM said its manufacturing PMI slipped to 50.3 in February after rising to 50.9 in January, but a reading above 50 still indicates growth.
RTTNews
|
11h 40min ago
Bay Street Likely To Open On Firm Note
Canadian shares are likely to open on a firm note Monday morning, tracking gains in European markets, and higher commodity prices.
Worries about new tariffs by U.S. effective Tuesday could weigh and limit market's upside.
RTTNews
|
13h 18min ago
Dollar Climbs Amidst Trade And Geopolitical Jitters
Trade tariff turbulence and uncertainty about peace in Ukraine lifted the Dollar Index during the week ended February 28.
RTTNews
|
13h 26min ago
